BUSINESS BRIEF
Established in 2010, the company is a manufacturer and supplier of Bulk Drug Intermediates, Fine Chemicals, Metal Reagents, Borane Reagents, and Grignard Reagents. Operating from Southern India, it serves both domestic and international markets, catering to major API and formulation companies.
- Maximum Output: 20,100 kg/day (weight-based production capacity)
- Installed Capacity: 166.3 KL (equipment and storage capacity)
- Expansion Potential: 90-100 KL of available space, allowing expansion up to 256.3 KL.
Certifications:
- DCA
- GMP DCA
- WHO GMP
- ISO 9001:2015
- ISO 14001:2015
- ISO 45001:2018
Manufacturing facility:
- Total Land Area: 6.2 acres (24,902 sq. meters)
- Built-up Area: 14,127 sq. meters
Team:
- Production: 59
- R&D: 30
- Quality Control: 22
- Engineering: 10
- Others (Warehouse, QA, HR, Finance, and EHS): 21
Strategic Advancements:
- Established a new manufacturing unit to focus on high-quality Active Pharmaceutical Ingredients (APIs) and their intermediates.
- Established State-of-the-Art R&D Center dedicated to new API development and contract research collaborations with leading global companies
Products & Services
- APIs & Intermediates
- Bulk Drug Intermediates
- Fine Chemicals
- Metal Reagents
- Borane Reagents
- Grignard Reagents – Aromatic, Aliphatic and Turbo
Proposal
Industry
Pharmaceuticals
Sub Industry
Bulk Drug & API manufacturing
Nature of Business
B2B
Sector
Manufacturing (Contract Manufacturing)
Reason for sell-off
Strategic Realignment or Pursuing New Opportunities
Location
India
Region
Southern
Open For Dilution
100 % (Complete Buyout)
Top Customer
Deal Size
INR 110 - 250 Cr
Justification
Based on Market multiples
Business Operation Information
Financial Information |
2024 (in INR Cr) | 2023 (in INR Cr) | 2022 (in INR Cr) |
---|---|---|---|
Sales |
83.59 | 68.91 | 63.19 |
EBITDA |
|||
PAT |